![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 16.00 | 15.50 | 16.50 | 16.00 | 16.00 | 16.00 | 38,250 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 5.63 | 14.59M |
Date | Subject | Author | Discuss |
---|---|---|---|
24/10/2016 23:16 | Will be Interesting to see whether it's this or another; either way prob not long to wait.Think chart may suggest some In know here | ![]() tsmith2 | |
24/10/2016 22:37 | His record of inside info on OPTI has been poor, as I don't think anything he says will take place has actually taken place, at any rate in recent times. | ![]() lukead | |
24/10/2016 22:28 | Someuwin - TW, has he not always been an insider from the IPO? "It's a bit bad of TW to publish partial info." So you thought it a good idea to do the same? Uhm! | elrico | |
24/10/2016 22:09 | he is unspeakably angry and no one has commented on that above post. It can't possibly be OPTI as they have enough cash to last before the MONEY MAKING COMMERCIAL DEALS COME THROUGH, so what are on about o/p | ![]() lukead | |
24/10/2016 21:33 | I hope none of today's selling was on the back of TW's cryptic comments. He said he had been made an insider this morning - and was furious about it. He couldn't tell us why or what it related to. But the obvious conclusion is that one of the companies he holds is trying to get a placing away. No reason to believe it relates to OPTI and imo It's a bit bad of TW to publish partial info. | ![]() someuwin | |
24/10/2016 21:07 | JH - Regardless. Is the market always correct? No it is not. I can point to every INDEX across the globe and be very confident is stating EVERYONE is expensive on PE's. The markets are being propped up with QE and FTSE....cheap sterling. So, I ask you, do you care? I'm very confident the bubble will burst, it just the timing and which trigger will cause it? My money is on EU bank imploding and or Stateside car/loan market, because lets face it, the Yanks never learn from past horrors. They are repeating the mortgage fiasco with the car/loan market. Will Deuchter Bank be the sacrificial lamb? | elrico | |
24/10/2016 21:05 | I wouldn't say relentless selling just drifting because of terribly awful volume. Probably caused by a mix of profit taking, lack of news on commercial deals, impatience and uncertainty of this apparent soon to happen de listing. This combination will obviously also put off buyers. All I would say is, and only if the technology, management and overall strategy has been fully scrutinised and you have absolute faith in your research: 'be fearful when others are greedy and greedy when others are fearful'. | ![]() riskybusiness1 | |
24/10/2016 20:12 | Soh has never promised deals or timeframes. 'I'd be disappointed if there wasn't 4/5 more deals by november' certainly does not clarify as a promise. If people scrutinised the successes of the company more and the CEOs enthusiasm less then they'd wouldn't be in the slightest bit worried | ![]() riskybusiness1 | |
24/10/2016 20:08 | Riskybusiness unfortunately the market doesn't share your view. Hence the relentless selling | ![]() john henry | |
24/10/2016 20:07 | Excellent post risky. I particularly like the references to the blue-chip shafting the minion. I was not aware of the Dupont & AB-Biotic. I'm confident SOH et al will be well aware of this, coupled with SOH 3M debacle - he will almost certainly be more guarded when it comes to signing deals with blue-chip clients. I am quite relaxed about the strategy, the length of time deals take to negotiate, etc. My philosophy has been centred on not making the "ASOS" mistake again.(bought @7.5p, sold initial stake at 26p and remainder at 110p - I never had the courage to buy back)With this in mind, my holdings are in 2014/15/16 ISA's. Try as I might, I cannot find another investment out there with anywhere near the same potential OPTI/Skinbiotix has. | elrico | |
24/10/2016 20:03 | When you look at the stock that's being dumped on LSE and Isdx day after day week after week, I'm very surprised the share price is not down another 20-30% | ![]() john henry | |
24/10/2016 19:52 | SOH has never PROMISED deals..so need to be careful before quoting our CEO! He said he'd be disappointed if they hadn't completed the deals before November. For all we know they might have completed them pending RNS wording/ legalities. | ![]() f3rdinand | |
24/10/2016 19:35 | uzbek1, i would not put it that style. ..... enduring patience during the last 10 months during which the share price has fluctuated within a relatively tight channel....... How do you get " a relatively tight channel " ? WHEN THE SHARE IS DOWN a massive 28% on the year end price which was 90p and now 65p i can see why the guys in at 8p are ok, the ones at 90/85/even at the high of 100 are not. Given the empty promises of an exciting ride in 2016, so far the guys like me are also not happy and if they are , i do not believe them. Yes we can sell and move on, many have. I would and i am positive that many would like to see SOH come on and announce something . Something like those products a poster got confused with last night selling an a major US supermarket, etc. | ![]() lukead | |
24/10/2016 19:28 | Radio 4 prog. today 'Start the Week' commences with an expert on the Biome - worth a listen (about 10 mins) x | ![]() grim | |
24/10/2016 19:18 | Dear Shareholders, I would firstly like to thank you for your enduring patience during the last 10 months during which the share price has fluctuated within a relatively tight channel. Regrettably my anticipation of multiple deals by the latter part of the year have yet to come to fruition due to extraordinary circumstances. However I can absolutely reassure you that the business is making huge strides towards agreements and commercialisation of our IP. I have been in discussion with a number of potential partners and at this stage can categorically say that the outcome will be extremely exciting for everyone associated with Optibiotix. I cannot yet give definitive timescales on completion of agreements and with whom but I ask for patience during this extremely exciting time for the business. Thank you again for your support. Lukead is the above the sort of response you would like to see from SOH next month if he cannot confirm deal completions? | ![]() uzbek1 | |
24/10/2016 19:14 | if you buy, they will come. | ![]() diamond fibre | |
24/10/2016 19:03 | Thanks risky it's nice to have a recap..and it's good for anyone new who pops in..let's hope we get some news that takes us to a higher share price level.. | ![]() bobdown2 | |
24/10/2016 18:54 | Judijudi - 18 Oct 2016 - 17:24:40 - 16444 of 16664 OptiBiotix - Better Science, Better Health. Better buy some! - OPTI Don't you like somebody pointing out what's plain for everyone to see? (Except it seems you) Do you live all your waking life in a Rose Tinted bubble? Get with the programme. Open your eyes. The facts are out there if you take the tinted specs off!!! Roll on the news that will bring in the buyers, that will actually make the price rise!! xoxoxoxoxoxoxoxoxoxo Mrs hypocrite comes to mind, there you were having a go at somebody ramping it up and actually you agree with me in that NEWS is the word and Risky with due respect, we know all that stuff, it's the buzz word, deals take time, disregard the present share price and all that jazz. Now he promised deals by November, lets give him till then to say something rather than empty promises. | ![]() lukead | |
24/10/2016 18:45 | To those who are starting to worry because of lack of news and share price drift:- The CEO has a holding far greater than any of ours combined. He'll act in the best interest of shareholders in every decision made as he clearly has more than us- the CEO sold his last company to a global corporate (3m). 3m did not sell the product anywhere near the numbers agreed in an earn out agreement. 3m priorities changed during the financial crisis - soh took them to court and I think he won.Clearly because of this he definitely won't be sold short even if it means snubbing the big guns. AB-biotic have a deal with DUPONT...at first glance this is great however just look at the sales. DuPont have screwed ab-life somewhat. What choice have they got now? That's exactly the type of deal we need to avoid. - opti at a current cash burn rate circa 80-100k a month with over £3m currently in the bank gives us a timeframe of nearly 3 years to get a half decent revenue bearing deal. This gives us the ability to find the right deal. Go figure is currently selling and cutting these small overheads as we speak (marginally but growing fast).- the most potentially lucrative platform: optibiotics recently announced its success in increasing the growth rate of specific strains e.g it's cholesterol product. This allows us to improve our already brilliant efficacy taken from our first trials. Potentially to statin reducing standards as we had a 7% reduction across the board with 36% reduction within the group with higher cholesterol levels. All with a minuscule dosage of 0.1g. The optibiotic technology platform used to enhance its cholesterol strain recently successfully holds a deal with dsm to create products that have a direct agreement that ends with us receiving royalties.Another part of this platform, the sweet healthy sugars that have no calories has recently been announced a success in its sweetness. This alone is a value enhancing step that the market payed no attention to due to its focus on the cholesterol deal.This means we have the means to target specific microbes increasing their growth rate giving a specific targeted health benefit. This is revolutionary to the whole industry. It also means we now have the ability to create a sweet sugar that can reduce your cholesterol. Put a value on that? If this is replicated with a diabetes strain targeted through our validated opti screen and then enhanced through our optibiotics platform then we are laughing. This would give us sweet tasting sugar that helps diabetic sufferers.If you really are worried with developments think why you invested in the first place. Then realise how far this company has come in 2 years and how these concepts are all turning in to realities. Let alone entering skin space due to the successes. The deals will come, just look at the technology compared to what's currently in the market. I've said before it's like moving from a road map to the sat nav. They're all going to do it it's just when and will you be in opti when it happens. The story has never been better here. Don't get blinded by a share price that has not reflected developments. | ![]() riskybusiness1 | |
24/10/2016 18:32 | From the link above:Chief Executive of Diabetes UK, Chris Askew, says: "As things stand we are certainly looking at a crisis in diabetes which threatens to bankrupt the NHS if we continue with these current trends."I believe we're facing a crisis and we really need concerted action right across society for us to fund more research, provide best possible care and crucially prevent so many cases of type 2 in future." | ![]() parob | |
24/10/2016 18:22 | TV programme relevant to OPTIhttp://www.bbc.c | ![]() parob | |
24/10/2016 16:30 | I did try and warn you guys what a child he was. Best you filter. Makes this bb much easier on the eye! | ![]() judijudi | |
24/10/2016 16:29 | I can lukead obviously you cannot,so either sell up or if you have already sold up which i reckon you have,move on. | ![]() scotty1 | |
24/10/2016 16:11 | Lukead - you are now beginning to sound like TT, the same person you were having a go at for saying these statements. Sell up and move on! Easy! | primal123 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions